AFM
INBS icon

Anson Funds Management’s Intelligent Bio Solutions INBS Stock Holding History

Anson Funds Management’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-238
Closed -$2.25M – 324
2021
Q2 		$2.25M Buy
+238
New +$2.28M 0.21% 119
2021
Q1 		– Sell
-13
Closed -$230K – 270
2020
Q4 		$230K Buy
+13
New +$285K 0.05% 150

Other funds holding INBS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
WP
WealthShield Partners Cary, North Carolina $654M AUM 26.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Anson Funds Management's INBS Position: Q3 2021 in Review

Anson Funds Management sold out of Intelligent Bio Solutions (INBS) in Q3 2021, closing a stake of 238 shares — an estimated $2.25M sold.

Anson Funds Management first reported a position in INBS in Q4 2020 and held it in 2 quarters. The position peaked at $2.25M in Q2 2021. 8 funds tracked by Wall St. Rank hold INBS as of Q3 2021.

  • Anson Funds Management reported no remaining Intelligent Bio Solutions position as of Q3 2021 after selling out during the quarter.
  • Anson Funds Management sold 238 Intelligent Bio Solutions shares in Q3 2021, an estimated $2.25M.
  • Anson Funds Management first reported a position in Intelligent Bio Solutions in Q4 2020 and held it in 2 quarters.
  • Anson Funds Management's Intelligent Bio Solutions position peaked at $2.25M in Q2 2021.
  • 8 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q3 2021.

Based on Anson Funds Management's 13F filing for Q3 2021, filed 15 Nov 2021.